Results
1
High return on equity, past performance and sound balance sheet.
1 companies
SK Biopharmaceuticals
Market Cap: ₩9.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩111,900.00
7D
-7.3%
1Y
8.4%